ImpediMed Limited Suite 31C, 12-18 Tryon Rd Lindfield NSW 2070 Australia E: investorrelations@impedimed.com W : impedimed.com 18 November 2026 Companies Announcements Office Australian Securities Exchange 2026 Annual General Meeting – CEO’s Presentation ImpediMed Limited (ImpediMed) (ASX:IPD)...
2026 AGM - CEO's Presentation
Filed with ASX · · 16 pages · English
Summary by 6ix AI
ImpediMed Limited has released the CEO's presentation for its Annual General Meeting, detailing the company's strategic direction and product offerings. The presentation highlights the SOZO® Digital Health Platform's value proposition and its applications in cancer survivorship and heart health. It emphasizes the importance of early detection and monitoring in improving patient outcomes and managing health risks. The document outlines the leadership team and their roles in driving the company's growth and innovation.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
In the deck
Earlier from ImpediMed
- 2026 AGM - Chair's Address
- Investor Presentation
- Quarterly Activities Report and Appendix 4C - Sep-2026 Qtr
- Change of Director's Interest Notice - Mr Andrew Grant
- Change of Director's Interest Notice - Ms Emmanuel-Donnelly
Later from ImpediMed
All ImpediMed news releasesFollow ImpediMed into a list and get an email when it puts out news.
Follow ImpediMed